0001659819-18-000002.txt : 20180718 0001659819-18-000002.hdr.sgml : 20180718 20180718134437 ACCESSION NUMBER: 0001659819-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180718 DATE AS OF CHANGE: 20180718 EFFECTIVENESS DATE: 20180718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Velicept Therapeutics, Inc. CENTRAL INDEX KEY: 0001659819 IRS NUMBER: 473400632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-317168 FILM NUMBER: 18958150 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD, SUITE 119 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-318-2988 MAIL ADDRESS: STREET 1: 640 LEE ROAD, SUITE 119 CITY: WAYNE STATE: PA ZIP: 19087 D 1 primary_doc.xml X0708 D LIVE 0001659819 Velicept Therapeutics, Inc. 640 LEE ROAD, SUITE 119 WAYNE PA PENNSYLVANIA 19087 484-318-2988 DELAWARE None None Corporation true 2015 James Walker 640 Lee Road, Suite 119 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Douglas Gessl 640 Lee Road, Suite 119 Wayne PA PENNSYLVANIA 19087 Executive Officer Stephen Tullman 640 Lee Road, Suite 119 Wayne PA PENNSYLVANIA 19087 Director Scott Morenstein 500 Park Avenue New York NY NEW YORK 10022 Director David Hirsch One Fawcett Place Greenwich CT CONNECTICUT 06830 Director James Bennethum 860 Porcupine Path Gaylord MI MICHIGAN 49735 Director Aidan King Two Docklands Central, Level 4 Guild Street, IFSC Dublin L2 IRELAND D01K2C5 Director Cory Freedman 628 Middlefield Road Palo Alto CA CALIFORNIA 94301 Director Pharmaceuticals Decline to Disclose 06b false 2018-07-12 false true false 0 15624000 15508713 115287 false 16 0 0 850000 true false Velicept Therapeutics, Inc. James Walker James Walker President and Chief Executive Officer 2018-07-18